These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9728442)

  • 21. Elevations in total plasma homocysteine in premature coronary artery, cerebrovascular and peripheral vascular disease.
    Bostom AG; Eaton CB; Yanek L; McQuade W; Catalfamo J; Selhub J
    Atherosclerosis; 1993 Aug; 102(1):121-4. PubMed ID: 8257448
    [No Abstract]   [Full Text] [Related]  

  • 22. Low vitamin B6, and not plasma homocysteine concentration, as risk factor for abdominal aortic aneurysm: a retrospective case-control study.
    Peeters AC; van Landeghem BA; Graafsma SJ; Kranendonk SE; Hermus AR; Blom HJ; den Heijer M
    J Vasc Surg; 2007 Apr; 45(4):701-5. PubMed ID: 17398378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Homocysteine--marker of vascular disease in elderly with mental illness].
    Hultberg B; Nilsson K; Gustafson L
    Lakartidningen; 2008 Sep 17-23; 105(38):2576-8. PubMed ID: 18846861
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hyperhomocysteinemia as a risk factor for vascular diseases].
    Ziegler R
    Med Monatsschr Pharm; 2006 Jun; 29(6):228-9. PubMed ID: 16792202
    [No Abstract]   [Full Text] [Related]  

  • 25. The potential role of homocysteine mediated DNA methylation and associated epigenetic changes in abdominal aortic aneurysm formation.
    Krishna SM; Dear A; Craig JM; Norman PE; Golledge J
    Atherosclerosis; 2013 Jun; 228(2):295-305. PubMed ID: 23497786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homocysteine and vascular disease.
    Robinson K
    Eur Heart J; 2002 Oct; 23(19):1482-4. PubMed ID: 12242065
    [No Abstract]   [Full Text] [Related]  

  • 27. Nutritional hyperhomocysteinaemia.
    Mohan IV; Stansby G
    BMJ; 1999 Jun; 318(7198):1569-70. PubMed ID: 10364097
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.
    Ueland PM; Refsum H
    J Lab Clin Med; 1989 Nov; 114(5):473-501. PubMed ID: 2681479
    [No Abstract]   [Full Text] [Related]  

  • 29. High levels of homocysteine, lipoprotein (a) and plasminogen activator inhibitor-1 are present in patients with abdominal aortic aneurysm.
    Sofi F; Marcucci R; Giusti B; Pratesi G; Lari B; Sestini I; Lo Sapio P; Pulli R; Pratesi C; Abbate R; Gensini GF
    Thromb Haemost; 2005 Nov; 94(5):1094-8. PubMed ID: 16363254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma homocysteine and methionine tolerance in early-onset vascular disease.
    Brattström L; Israelsson B; Hultberg B
    Haemostasis; 1989; 19 Suppl 1():35-44. PubMed ID: 2680811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperhomocysteinaemia and aortic calcification are associated with fractures in patients on haemodialysis.
    Jamal SA; Leiter RE; Bauer DC
    QJM; 2005 Aug; 98(8):575-9. PubMed ID: 15983022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial hyperhomocysteinaemia and endothelium-dependent vasodilatation and arterial distensibility of large arteries.
    Lambert J; van den Berg M; Steyn M; Rauwerda JA; Donker AJ; Stehouwer CD
    Cardiovasc Res; 1999 Jun; 42(3):743-51. PubMed ID: 10533615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hyperhomocysteinemia--a new risk factor for vascular diseases?].
    Brattström L; Israelsson B; Hultberg B
    Lakartidningen; 1992 Feb; 89(7):467-9. PubMed ID: 1738269
    [No Abstract]   [Full Text] [Related]  

  • 34. Abnormalities of vascular function in hyperhomocysteinaemia: relationship to atherothrombotic disease.
    Stehouwer CD; Jakobs C
    Eur J Pediatr; 1998 Apr; 157 Suppl 2():S107-11. PubMed ID: 9587036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyperhomocysteinemia--a risk factor or vascular disease?].
    Bar-Meir E; George J; Shoenfeld Y
    Harefuah; 1999 Jan; 136(2):129-33. PubMed ID: 10914181
    [No Abstract]   [Full Text] [Related]  

  • 36. Homocysteine in vascular disease: an emerging clinical perspective.
    Jacobs P; Wood L; Bick R
    Cardiovasc J S Afr; 2006; 17(3):135-9. PubMed ID: 16807631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The redox status of aminothiols as a clue to homocysteine-induced vascular damage?
    Koch HG; Goebeler M; Marquardt T; Roth J; Harms E
    Eur J Pediatr; 1998 Apr; 157 Suppl 2():S102-6. PubMed ID: 9587035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperhomocysteinaemia, low folate concentrations and MTHFR C677T mutation in abdominal aortic aneurysm.
    Cao H; Hu X; Zhang Q; Li J; Liu B; Wang J; Shao Y; Zhang Z; Liu C; Hu H; Zhang J; Xin S
    Vasa; 2014 May; 43(3):181-8. PubMed ID: 24797049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total homocysteine as a risk factor for vascular disease in renal transplant recipients.
    Juskowa J; Bartłomiejczyk J; Paczek L; Rowinski W; Szmidt J; Foroncewicz B; Mucha K; Plomiński YP
    Transplant Proc; 2002 Mar; 34(2):576-9. PubMed ID: 12009629
    [No Abstract]   [Full Text] [Related]  

  • 40. The case for mild hyperhomocysteinaemia as a risk factor.
    Boers GH
    J Inherit Metab Dis; 1997 Jun; 20(2):301-6. PubMed ID: 9211202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.